TN2009000199A1 - Heteromonocyclic compound and use thereof - Google Patents

Heteromonocyclic compound and use thereof

Info

Publication number: TN2009000199A1
Authority: TN; Tunisia
Prior art keywords: formula; compound; group represented; diseases; heteromonocyclic compound
Prior art date: 2006-11-24

Application number

TNP2009000199A

Other languages

English (en)

Inventor

Takanobu Kuroita

Hiroki Sakamoto

Hideyuki Igawa

Minoru Sasaki

Kouhei Asano

Tsuyoshi Maekawa

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-11-24

Filing date

2009-05-20

Publication date

2010-10-18

2009-05-20 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2010-10-18 Publication of TN2009000199A1 publication Critical patent/TN2009000199A1/fr

Links

-1 Heteromonocyclic compound Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
208000015114 central nervous system disease Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
208000030159 metabolic disease Diseases 0.000 abstract 1
125000004043 oxo group Chemical group O=* 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

TNP2009000199A 2006-11-24 2009-05-20 Heteromonocyclic compound and use thereof TN2009000199A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2006317839		2006-11-24
JP2007232106		2007-09-06
PCT/JP2007/073004 WO2008062905A2 (fr)	2006-11-24	2007-11-21	Composé hétéromonocyclique et ses utilisations

Publications (1)

Publication Number	Publication Date
TN2009000199A1 true TN2009000199A1 (en)	2010-10-18

Family

ID=39205144

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2009000199A TN2009000199A1 (en)	2006-11-24	2009-05-20	Heteromonocyclic compound and use thereof

Country Status (21)

Country	Link
US (2)	US20080207654A1 (fr)
EP (2)	EP2256115A1 (fr)
JP (1)	JP2010510962A (fr)
KR (1)	KR20090085117A (fr)
AR (1)	AR063912A1 (fr)
AU (1)	AU2007322608A1 (fr)
BR (1)	BRPI0719060A2 (fr)
CA (1)	CA2670404A1 (fr)
CL (1)	CL2007003352A1 (fr)
CO (1)	CO6231035A2 (fr)
CR (1)	CR10847A (fr)
EA (1)	EA200970510A1 (fr)
EC (1)	ECSP099461A (fr)
IL (1)	IL198819A0 (fr)
MA (1)	MA30985B1 (fr)
MX (1)	MX2009005449A (fr)
NO (1)	NO20092415L (fr)
PE (1)	PE20081228A1 (fr)
TN (1)	TN2009000199A1 (fr)
TW (1)	TW200829581A (fr)
WO (1)	WO2008062905A2 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7103906B1 (en)	2000-09-29	2006-09-05	International Business Machines Corporation	User controlled multi-device media-on-demand system
ES2312475T3 (es)	2000-10-11	2009-03-01	United Video Properties, Inc.	Sistemas y metodos para proporcionar el almacenamiento de datos en servidores de un sistema de entrega de medios bajo demanda.
US8086575B2 (en)	2004-09-23	2011-12-27	Rovi Solutions Corporation	Methods and apparatus for integrating disparate media formats in a networked media system
US9681105B2 (en)	2005-12-29	2017-06-13	Rovi Guides, Inc.	Interactive media guidance system having multiple devices
US8607287B2 (en)	2005-12-29	2013-12-10	United Video Properties, Inc.	Interactive media guidance system having multiple devices
CA2670404A1 (fr) *	2006-11-24	2008-05-29	Takeda Pharmaceutical Company Limited	Compose heteromonocyclique et ses utilisations
US7803940B2 (en) *	2006-11-24	2010-09-28	Takeda Pharmaceutical Company Limited	Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
US20090019492A1 (en)	2007-07-11	2009-01-15	United Video Properties, Inc.	Systems and methods for mirroring and transcoding media content
EA019823B1 (ru) *	2009-01-30	2014-06-30	Такеда Фармасьютикал Компани Лимитед	КОНДЕНСИРОВАННЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ ПИРИМИДИНОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ АГОНИСТА АНГИОТЕНЗИНА II И АГОНИСТА γ-РЕЦЕПТОРА, АКТИВИРУЮЩЕГО ПРОЛИФЕРАЦИЮ ПЕРОКСИСОМ
US20110306623A1 (en)	2009-02-23	2011-12-15	Kowa Company, Ltd.	Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
WO2010119700A1 (fr)	2009-04-17	2010-10-21	興和株式会社	Nouveau composé ayant une structure 3-hétéroarylpyrimidin-4-(3h)-one et préparation pharmaceutique contenant celui-ci
EP2436675A1 (fr)	2009-05-29	2012-04-04	Kowa Company, Ltd.	Nouveau dérivé d'acide -phénoxybenzèneacétique et préparation pharmaceutique le contenant
EP2471782A4 (fr)	2009-08-27	2013-03-20	Kowa Co	Nouveau dérivé de sulfonamide et composition pharmaceutique le contenant
US9014546B2 (en)	2009-09-23	2015-04-21	Rovi Guides, Inc.	Systems and methods for automatically detecting users within detection regions of media devices
ES2527226T3 (es)	2009-09-29	2015-01-21	Kowa Company, Ltd.	Nuevo derivado fenilpiridina y agente médico que comprende el mismo
JPWO2011077711A1 (ja) *	2009-12-22	2013-05-02	興和株式会社	新規な２−ピリドン誘導体及びこれを含有する医薬
WO2011105099A1 (fr) *	2010-02-25	2011-09-01	興和株式会社	Composé contenant une nouvelle formation de 4-alcoxypyridine et médicament la contenant
EP2581373A4 (fr) *	2010-05-11	2013-10-23	8337187 Canada Inc	Dérivé benzo- ou pyrido-imidazole
JPWO2012011592A1 (ja) *	2010-07-23	2013-09-09	武田薬品工業株式会社	複素環化合物およびその用途
CA2813911A1 (fr)	2010-10-07	2012-04-12	Takeda Pharmaceutical Company Limited	Derives de 1,4-oxazepane
ES2697607T3 (es)	2010-12-06	2019-01-25	Aclaris Therapeutics Inc	Compuestos sustituidos de piridinon-piridinilo
US9359300B2 (en)	2010-12-06	2016-06-07	Confluence Life Sciences, Inc.	Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
US8507499B2 (en)	2010-12-06	2013-08-13	Confluence Life Sciences, Inc.	Substituted indole/indazole-pyrimidinyl compounds
WO2012078673A1 (fr)	2010-12-06	2012-06-14	Confluence Life Sciences, Inc.	Composés urée-pyridine substitués
ES2562994T3 (es)	2011-03-14	2016-03-09	Kowa Company Ltd.	Nuevo derivado de fenilpiridina y medicamento que contiene el mismo
EP2567959B1 (fr)	2011-09-12	2014-04-16	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
WO2013086208A1 (fr)	2011-12-06	2013-06-13	Confluence Life Sciences, Inc.	Composés de pyrimidinone-phényl-pyrimidinyle substitués
AU2012356374B2 (en) *	2011-12-21	2017-06-22	Ono Pharmaceutical Co., Ltd.	Pyridinone and pyrimidinone derivatives as factor XIa inhibitors
JO3470B1 (ar)	2012-10-08	2020-07-05	Merck Sharp & Dohme	مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
US9115089B2 (en)	2013-06-07	2015-08-25	Confluence Life Sciences, Inc.	Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
ES2761571T3 (es)	2013-06-20	2020-05-20	Bayer Cropscience Ag	Derivados de arilsulfuro y arilsulfóxido como acaricidas e insecticidas
ES2712211T3 (es)	2013-06-20	2019-05-09	Bayer Cropscience Ag	Derivados de arilsulfuro y arilsulfóxido acaricidas e insecticidas
US9674563B2 (en)	2013-11-04	2017-06-06	Rovi Guides, Inc.	Systems and methods for recommending content
CN104725356B (zh)	2013-12-19	2017-02-22	广东东阳光药业有限公司	氮杂环衍生物及其在药物中的应用
RU2693622C2 (ru)	2014-04-01	2019-07-03	Мерк Шарп И Доум Корп.	Пролекарственные средства ингибиторов обратной транскриптазы вич
JP6610562B2 (ja)	2014-12-10	2019-11-27	小野薬品工業株式会社	ジヒドロインドリジノン誘導体
EA201990242A1 (ru)	2016-07-12	2019-07-31	Байер Кропсайенс Акциенгезельшафт	Бициклические соединения в качестве средств для борьбы с вредителями
KR101984121B1 (ko) *	2017-08-21	2019-05-30	보령제약 주식회사	피리미디논 유도체 화합물 및 이의 용도
EP4125891A4 (fr)	2020-03-27	2024-08-21	Aclaris Therapeutics, Inc.	Procédé, compositions et formes cristallines de composés pyridinone-pyridinyle substitués
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5411980A (en) *	1989-07-28	1995-05-02	Merck & Co., Inc.	Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
JPH03218371A (ja)	1989-08-02	1991-09-25	Takeda Chem Ind Ltd	ピラゾール誘導体
DE69013607T2 (de) *	1989-08-02	1995-03-02	Takeda Chemical Industries Ltd	Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
DE69129998T2 (de)	1990-02-15	1998-12-24	Takeda Chemical Industries, Ltd., Osaka	Pyrimidindionderivate, deren Herstellung und Verwendung
JP3032844B2 (ja)	1990-02-15	2000-04-17	武田薬品工業株式会社	ピリミジンジオン誘導体
CA2037630C (fr) *	1990-03-07	2001-07-03	Akira Morimoto	Composes heterocycliques renfermant de l'azote, methode de production et applications correspondantes
JP3114073B2 (ja)	1990-03-07	2000-12-04	武田薬品工業株式会社	アンジオテンシンｉｉ拮抗薬−含窒素異項環化合物
US5166206A (en) *	1990-03-30	1992-11-24	Merck & Co., Inc.	Substituted pyrimidines, pyrimidinones and pyridopyrimidines
US5472967A (en) *	1991-02-20	1995-12-05	Synthelabo	4-pyrimidinone derivatives their preparation and their application in therapy
IL102183A (en) *	1991-06-27	1999-11-30	Takeda Chemical Industries Ltd	Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
IT1250749B (it) *	1991-08-02	1995-04-21	Luso Farmaco Inst	Composti eterociclici ad attivita' a ii antagonista
ATE167861T1 (de)	1992-09-14	1998-07-15	Takeda Chemical Industries Ltd	1,2,4-oxadiazolyl oder 1,2,4-thiadiazolyl- derivate als angiotensin ii antagonisten
JPH06239859A (ja)	1992-09-14	1994-08-30	Takeda Chem Ind Ltd	アンギオテンシンｉｉ拮抗作用を有する環状化合物およびその用途
JP3412887B2 (ja)	1992-12-22	2003-06-03	武田薬品工業株式会社	アンギオテンシンｉｉ拮抗作用を有する複素環化合物およびその用途
ATE204276T1 (de) *	1992-12-22	2001-09-15	Takeda Chemical Industries Ltd	Heterocyclische verbindungen mit angiotensin-ii- antagonistischer wirkung und ihre anwendung
US20010020100A1 (en) *	1994-06-14	2001-09-06	G.D. Searle & Co.	N-substituted-1, 2, 4-triazolone compounds for treatment of cardiovascular disorders
US6025372A (en)	1997-04-04	2000-02-15	Merck & Co., Inc.	Somatostatin agonists
US6057338A (en)	1997-04-04	2000-05-02	Merck & Co., Inc.	Somatostatin agonists
AU1285499A (en)	1997-10-30	1999-05-24	Merck & Co., Inc.	Somatostatin agonists
AR035016A1 (es)	1999-08-25	2004-04-14	Takeda Chemical Industries Ltd	Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
CA2386517A1 (fr)	1999-10-07	2001-04-12	Takeda Chemical Industries, Ltd.	Derives d'amines
MY141468A (en)	1999-11-10	2010-04-30	Takeda Pharmaceutical	5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
PT1285651E (pt)	2000-04-28	2010-10-21	Takeda Pharmaceutical	Antagonistas da hormona concentradora da melanina
US7229986B2 (en)	2000-05-16	2007-06-12	Takeda Pharmaceutical Company Ltd.	Melanin-concentrating hormone antagonist
AU2001269516B2 (en)	2000-07-13	2006-09-14	Takeda Pharmaceutical Company Limited	Lipid-rich plaque regressing agents
WO2003042204A1 (fr)	2001-10-19	2003-05-22	Takeda Chemical Industries, Ltd.	Derive d'amine
CN1615305A (zh)	2002-01-11	2005-05-11	武田药品工业株式会社	香豆素衍生物、生产它们的方法及其用途
CA2507026A1 (fr)	2002-11-22	2004-06-10	Takeda Pharmaceutical Company Limited	Derives d'imidazole, leur procede de production et d'utilisation
US7803940B2 (en) *	2006-11-24	2010-09-28	Takeda Pharmaceutical Company Limited	Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
CA2670404A1 (fr) *	2006-11-24	2008-05-29	Takeda Pharmaceutical Company Limited	Compose heteromonocyclique et ses utilisations

2007
- 2007-11-21 CA CA002670404A patent/CA2670404A1/fr not_active Abandoned
- 2007-11-21 EP EP10173592A patent/EP2256115A1/fr not_active Withdrawn
- 2007-11-21 US US11/943,910 patent/US20080207654A1/en not_active Abandoned
- 2007-11-21 EP EP07832719A patent/EP2074117A2/fr not_active Withdrawn
- 2007-11-21 AU AU2007322608A patent/AU2007322608A1/en not_active Abandoned
- 2007-11-21 KR KR1020097012959A patent/KR20090085117A/ko not_active Withdrawn
- 2007-11-21 BR BRPI0719060-3A2A patent/BRPI0719060A2/pt not_active IP Right Cessation
- 2007-11-21 MX MX2009005449A patent/MX2009005449A/es not_active Application Discontinuation
- 2007-11-21 JP JP2009521472A patent/JP2010510962A/ja not_active Abandoned
- 2007-11-21 WO PCT/JP2007/073004 patent/WO2008062905A2/fr active Application Filing
- 2007-11-21 US US12/516,099 patent/US20100056526A1/en not_active Abandoned
- 2007-11-21 EA EA200970510A patent/EA200970510A1/ru unknown
- 2007-11-23 PE PE2007001629A patent/PE20081228A1/es not_active Application Discontinuation
- 2007-11-23 AR ARP070105204A patent/AR063912A1/es not_active Application Discontinuation
- 2007-11-23 CL CL200703352A patent/CL2007003352A1/es unknown
- 2007-11-23 TW TW096144409A patent/TW200829581A/zh unknown
2009
- 2009-05-19 IL IL198819A patent/IL198819A0/en unknown
- 2009-05-20 TN TNP2009000199A patent/TN2009000199A1/fr unknown
- 2009-06-09 CR CR10847A patent/CR10847A/es unknown
- 2009-06-10 MA MA31977A patent/MA30985B1/fr unknown
- 2009-06-23 EC EC2009009461A patent/ECSP099461A/es unknown
- 2009-06-24 CO CO09065607A patent/CO6231035A2/es not_active Application Discontinuation
- 2009-06-24 NO NO20092415A patent/NO20092415L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ECSP099461A (es)	2009-11-30
EA200970510A1 (ru)	2009-12-30
PE20081228A1 (es)	2008-10-29
JP2010510962A (ja)	2010-04-08
CR10847A (es)	2009-07-13
IL198819A0 (en)	2010-02-17
CL2007003352A1 (es)	2008-07-04
AR063912A1 (es)	2009-02-25
US20100056526A1 (en)	2010-03-04
CO6231035A2 (es)	2010-12-20
KR20090085117A (ko)	2009-08-06
MA30985B1 (fr)	2009-12-01
CA2670404A1 (fr)	2008-05-29
TW200829581A (en)	2008-07-16
WO2008062905A2 (fr)	2008-05-29
US20080207654A1 (en)	2008-08-28
EP2074117A2 (fr)	2009-07-01
NO20092415L (no)	2009-08-17
WO2008062905A3 (fr)	2008-12-04
EP2256115A1 (fr)	2010-12-01
BRPI0719060A2 (pt)	2014-02-04
AU2007322608A2 (en)	2009-07-16
AU2007322608A1 (en)	2008-05-29
MX2009005449A (es)	2009-06-02

Publication	Publication Date	Title
TN2009000199A1 (en)	2010-10-18	Heteromonocyclic compound and use thereof
TN2012000152A1 (en)	2013-12-12	Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
UY31803A (es)	2009-12-14	Compuesto cristalino
CO6382126A2 (es)	2012-02-15	Compuestos heteroaromaticos fusionados y espirociclicos para el tratamiento de infecciones bacterianas
MY168201A (en)	2018-10-15	Agricultural And Horticultural Fungicidal Composition
MY148429A (en)	2013-04-30	Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
PH12012500903A1 (en)	2014-09-24	N1 - pyrazolospiroketone acetyl-coa carboxylase inhibitors
TN2012000248A1 (en)	2013-12-12	Novel spiropiperidine compounds
PH12013500880A1 (en)	2013-07-01	Pyrazole aminopyrimidine derivatives as lrrk2 modulators
MX358682B (es)	2018-08-31	Derivados de pirazolo [1,5a]pirimidina y de tieno[3,2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
MX2014006026A (es)	2014-06-04	Derivados de aminopirimidina como moduladores de proteina cinasa 2 rica en unidades repetitivas de leucina (lrrk2).
JO2741B1 (en)	2014-03-15	Spiro-cyclic nitroblast as protease inhibitors
WO2007108936A3 (fr)	2007-11-01	Azacyclylamines avec substitution n en tant qu'antagonistes de l'histamine-3
NO20082096L (no)	2008-05-29	Azaindol-2-karboksamidderivativer
UA109290C2 (uk)	2015-08-10	Спільні кристали і солі інгібіторів ccr3
GEP20166483B (en)	2016-05-25	Phenyl-3-aza-bicyclo[3.1.0] hex-3-yl-methanones and the use thereof as medicament
GEP20166481B (en)	2016-05-25	(crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors
MX2010002899A (es)	2010-04-09	Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3.
GEP20135806B (en)	2013-04-10	Lactams as beta secretase inhibitors
WO2007136668A3 (fr)	2008-01-24	N-benzoyle et n-benzylpyrrolidin-3-ylamines comme antagonistes de l'histamine-3
EA200700909A1 (ru)	2007-12-28	Азаиндолкарбоксамиды
MX2008011576A (es)	2008-09-22	Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
JO2999B1 (ar)	2016-09-05	مركب ثلاثي حلقي و استخدامه الدوائي
TW200740766A (en)	2007-11-01	Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6-ligands
MY153733A (en)	2015-03-13	Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same